The FGF19/FGFR4 pathway activates GSK3β/β-catenin, PI3K/AKT, PLCγ/DAG/PKC, RAS/RAF/MAPK signaling cascades and promotes the survival, proliferation, and metastasis of HCC (77). The gene discussed is PRRT2; the disease is hepatocellular carcinoma.